Latest Breaking News On - Roger jeffs - Page 2 : comparemela.com

Axsome Therapeutics, Inc (NASDAQ:AXSM) Given Average Recommendation of Moderate Buy by Analysts

Axsome Therapeutics, Inc (NASDAQ:AXSM) Given Average Recommendation of Moderate Buy by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandUnited statesRobertw bairdMarkl jacobsonRoger jeffsAxsome therapeutics incPhocas financial corpWellington management groupVictory capital management incSecurities exchange commissionKennedy capital managementRoyal bankAxsome therapeuticsGet free reportMarketbeat ratings

Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

District of columbiaUnited statesSan diegoPatrick wallaceRoger jeffsPharmosa biopharmJason adairDrug administrationCorporate communicationsDelaware district court case noAmerican thoracic societyUs district courtUnited therapeutics corporationDistrict courtLiquidia technologies incLiquidia corporation

Liquidia Corporation Reports First Quarter 2024 Financial

Liquidia Corporation Reports First Quarter 2024 Financial
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

District of columbiaUnited statesSan diegoJason adairPharmosa biopharmRoger jeffsPatrick wallaceDrug administrationCorporate communicationsDelaware district court case noAmerican thoracic societyUs district courtUnited therapeutics corporationDistrict courtSandoz incInternational conference

Axsome Therapeutics (NASDAQ:AXSM) Given New $106 00 Price Target at Mizuho

Axsome Therapeutics (NASDAQ:AXSM) Given New $106 00 Price Target at Mizuho
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRoger jeffsPiper sandlerMarkl jacobsonSecurities exchange commissionCovestor ltdRussell investments group ltdAxsome therapeutics incWashington trust advisors incCantor fitzgeraldFifth third bancorpThird bancorpChina universal asset management coRoyal bankAxsome therapeuticsFree report

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $112 00

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $112 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdRoger jeffsMarkl jacobsonSecurities exchange commissionAxsome therapeutics company profileRussell investments group ltdCantor fitzgeraldMorgan stanleyAxsome therapeutics incWashington trust advisors incThird bancorpFifth third bancorpChina universal asset management coJaniczek wealth managementAxsome therapeutics